IndiTreat® – CRC Colorectal Cancer (CE-IVD)
2cureX developed the IndiTreat® test.
IndiTreat® matches the individual colorectal cancer patient with the most effective cancer treatment.

From a small tissue sample (primary tumor or metastasis) we generate thousands of 3D micro-tumors (tumoroids) that have the same properties as the tumor/metastasis in the individual patient. The tumoroids are challenged with single drugs or drug-combinations. Immediately after finalization of the test, the patient will be put on the IndiTreat® guided treatment. This is possible as the treatments tested are all approved by the health authorities. The test panel of treatments are customized according to the physician’s choice.

Key benefits IndiTreat®

  • Ability to provide patients with Individualized cancer treatments
  • No time wasted on treatment decisions that will not benefit the patient
  • Avoid tumor-resistance saves the patient from side-effects and society from wasted funds
  • Implementing the IndiTreat® test is easy and will not disturb other oncology care processes

IndiTreat® will give caregivers the confidence that patients are treated individually to target their tumor most efficiently

IndiTreat® – CRC is available as a CE IVD Validated test

For more information please contact 2cureX
Phone: +45 2211 5399

Contact information

Laboratory: 2cureX, Fruebjergvej 3, 2100 Copenhagen Ø, Denmark| Phone: +45 2211 5399| E-mail:

Privacy Policy | Imprint